Shanghai Hengrui Pharmaceutical Co., Ltd.

Related records

Trials (59)

• A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors
• A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary Hyperparathyroidism
• A Phase 1 Study of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Negative Metastatic or Locally Advanced Breast Cancer
• A Phase 1 Study of SHR-A2102 in Subjects With Advanced Solid Tumors.
• A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Subjects
• A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
• A Phase I Study of SHR-3836 in Patients With Multiple Myeloma
• A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
• A Phase II Study of SHR-4602 as Montherapy or in Combination With Other Anti-tumor Therapies in Advanced Solid Tumors
• A Phase III Study of SHR-A2102 Versus Investigator-selected Therapy in Advanced Urothelial Carcinoma
• A Study of HR18034 for Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy
• A Study of HR19024 in Subjects With Advanced Solid Tumor
• A Study of HRS2543 in Patients With Advanced Tumors
• A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC
• A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects
• A Study of SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
• A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
• A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
• A Study of SHR-A1904 in Patients With Advanced Solid Cancer
• A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors